Semin Vasc Med 2001; 01(1): 055-060
DOI: 10.1055/s-2001-14541
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Diagnosis of Recurrent Deep Vein Thrombosis

Paolo Prandoni, Enrico Bernardi, Daniela Tormene, Laura Mosena, Donatella Sartor, Antonio Girolami
  • Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy
Further Information

Publication History

Publication Date:
31 December 2001 (online)

ABSTRACT

Long-term follow-up studies demonstrated that venous thromboembolism is a chronic disease, as the rate of recurrent deep vein thrombosis (DVT) continuously increases after the primitive thrombotic episode.

Objective testing is mandatory to confirm or refute the presence of recurrent DVT, as only 30% of patients with suspected recurrence have a new documented thrombotic episode. There is no consensus on the preferred diagnostic procedure; furthermore, both invasive and noninvasive methods are limited in this context. Venography, the established gold standard, is invasive, costly, inconvenient and requires high technical skills. Among noninvasive techniques, serial impedance plethysmography, alone or in combination with leg scanning and venography, and serial compression ultrasound (CUS), were adequately investigated.

At present, the recommended approach is represented by a quantitative CUS method that possesses an excellent reproducibility and accuracy. The safety of withholding anticoagulants from patients with a normal quantitative CUS work-up has been recently demonstrated in a prospective management study.

REFERENCES

  • 1 Prandoni P, Lensing A WA, Cogo A. The long-term clinical course of acute deep venous thrombosis.  Ann Intern Med . 1996;  125 1-7
  • 2 Simioni P, Prandoni P, Lensing A W. The risk of recurrent venous thromboembolism in patients with an Arg506→Gln mutation in the gene for factor V (factor V Leiden).  N Engl J Med . 1997;  336 399-403
  • 3 Simioni P, Prandoni P, Lensing A WA. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.  Blood . 2000;  96 3329-3333
  • 4 Schulman S, Rhedin A S, Lindmarker P. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism.  N Engl J Med . 1995;  332 1661-1665
  • 5 Grau E, Real E, Medrano J, Pastor E, Selfa S. Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting.  Thromb Res . 1999;  96 335-341
  • 6 Kearon C, Gent M, Hirsh J. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.  N Engl J Med . 1999;  340 901-907
  • 7 Margaglione M, D'Andrea G, Colaizzo D. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.  Thromb Haemost . 1999;  82 1583-1587
  • 8 Hull R D, Raskob G E, Brant R F, Pineo G F, Valentine K A. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.  Arch Intern Med . 1997;  157 2317-2321
  • 9 Schulman S, Granqvist S, Holmström M. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism.  N Engl J Med . 1997;  336 393-398
  • 10 Franzeck U K, Schalch I, Jäger K A, Schneider E, Grimm J, Bollinger A. Prospective 12-year follow-up study of clinical and haemodinamic sequelae after deep vein thrombosis in low-risk patients (Zürich study).  Circulation . 1996;  93 74-79
  • 11 Hainaut P, Azerad M A, Lehmann F. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study.  J Int Med . 1997;  241 427-433
  • 12 De Stefano V, Martinelli I, Mannucci P M. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.  N Engl J Med . 1999;  341 801-806
  • 13 Hull R D, Raskob G E, Brant R F, Pineo G F, Valentine K A. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.  Arch Intern Med . 1997;  157 2562-2568
  • 14 Lensing A WA, Prins M H, Davidson B L, Hirsh J. Treatment of deep venous thrombosis with low-molecular weight heparins. A meta-analysis.  Arch Intern Med . 1995;  155 601-607
  • 15 Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg J S. Low-molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.  Am J Med . 1996;  100 269-277
  • 16 Anand S S, Bates S, Ginsberg J S. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.  Arch Intern Med . 1999;  27 2029-2032
  • 17 Fennerty A G, Dolben J, Thomas P. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism.  Clin Lab Haemat . 1987;  9 17-21
  • 18 Haeger K. Problems of acute deep-vein thrombosis: the interpretation of signs and symptoms.  Angiology . 1969;  20 219-223
  • 19 Hull R D, Carter C J, Jay R M. The diagnosis of acute recurrent deep-vein thrombosis: a diagnostic challenge.  Circulation . 1983;  67 901-906
  • 20 Huisman M V, Büller H R, ten Cate W J. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis.  Arch Int Med . 1988;  148 681-683
  • 21 Prandoni P, Cogo A, Bernardi E. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis.  Circulation . 1993;  88 1730-1735
  • 22 Kraaijenhagen R A, Lensing A W, Lijmer J G. Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis.  Curr Opin Pulm Med . 1997;  3 268-274
  • 23 Kearon C, Julian J A, Newman T E, Ginsberg J S. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative.  Ann Intern Med . 1998;  128 663-677
  • 24 Koopman M M, Buller H R, ten Cate W J. Diagnosis of recurrent deep vein thrombosis.  Haemostasis . 1995;  25 49-57
  • 25 Belcaro G. Evaluation of recurrent deep venous thrombosis using colour duplex scanning-comparison with venography.  Vasa . 1992;  21 22-26
  • 26 Huisman M V. Recurrent venous thromboembolism: diagnosis and management.  Curr Opin Pulm Med . 2000;  6 330-334
  • 27 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg.  Arch Surg . 1972;  104 134-144
  • 28 Ruehm S G, Wiesner W, Debatin J F. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience.  Radiology . 2000;  215 421-427
  • 29 Baldt M M, Zontsich T, Stumpfelen A. Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis.  Radiology . 1996;  200 423-428
  • 30 Leclerc J R, Jay R M, Hull R D, Hirsh J. Recurrent leg symptoms following deep vein thrombosis.  Arch Intern Med . 1985;  145 1867-1869
  • 31 Huisman M V, Büller H R, ten Cate W J, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients.  N Engl J Med . 1986;  314 823-886
  • 32 Jay R, Hull R D, Carter C J. Outcome of abnormal impedance plethysmography results in patients with proximal-vein thrombosis: frequency of return to normal.  Thromb Res . 1984;  36 259-263
  • 33 Prandoni P, Lensing A W, Buller H. Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis.  Thromb Haemost . 1991;  65 233-236
  • 34 Anderson D R, Lensing A W, Wells P S. Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis.  Ann Intern Med . 1993;  118 25-30
  • 35 Heijboer H, Büller H R, Lensing A WA, Turpie A GG, Colly L P, ten Cate W J. A comparison of real-time ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.  N Engl J Med . 1993;  329 1365-1369
  • 36 Lensing A WA, Prandoni P, Brandjes D. Detection of deep-vein thrombosis by real-time B-mode ultrasonography.  N Engl J Med . 1989;  320 342-345
  • 37 Heijboer H, Joenbloets L M, Buller H, Lensing A W, ten Cate W J. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis.  Acta Radiol . 1992;  33 297-300
  • 38 Cronan J, Leen V. Recurrent deep venous thrombosis: limitations of US.  Radiology . 1989;  170 739-742
  • 39 Murphy T P, Cronan J. Evolution of deep venous thrombosis: a prospective evaluation with US.  Radiology . 1990;  177 543-548
  • 40 van Ramshorst B, van Bemmelen S P, Hoeneveld H, Faber J A, Eikebloom B C. Thrombus regression in deep venous thrombosis: quantification of spontaneous thrombolysis with duplex scanning.  Circulation . 1992;  86 414-419
  • 41 Koopman M M, Jongbloets L, Lensing A W. Clinical utility of a quantitative B-mode ultrasonography method in patients with suspected recurrent deep-vein thrombosis.  Thromb Haemostas . 1993;  69 623
  • 42 Prandoni P, Lensing A W, Bernardi E. A novel ultrasound protocol for the diagnosis of symptomatic recurrent deep-vein thrombosis.  Haemostasis . 2000;  46 (46)
  • 43 Hull R D, Hirsh J, Sackett D L. Clinical validity of a negative venogram in patients with clinically suspected deep-vein thrombosis.  Circulation . 1981;  64 622-625
  • 44 Leclerc J R, Illescas F, Jarzem P. Diagnosis of deep vein thrombosis. In: Leclerc JR, ed. Venous Thromboembolic Disorders Philadelphia: Lea & Febiger 2000: 176-228
  • 45 Bernardi E, Prandoni P, Lensing A WA. D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study.  Br Med J . 1998;  317 1037-1040
    >